Similar to the results observed in CRC cells, the expression of MDR1, MRP1 and ABCG2 was also increased in the DOX-treated xenograft tumors and the increase was significantly prevented by fidarestat (Fig. 5B,C,D). This evidence concerns the gene ABCB1 and colorectal carcinoma.